2017
DOI: 10.1021/acs.jmedchem.6b01583
|View full text |Cite
|
Sign up to set email alerts
|

Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies

Abstract: The BRPF (bromodomain and PHD finger-containing) family are scaffolding proteins important for the recruitment of histone acetyltransferases of the MYST family to chromatin. Evaluation of the BRPF family as a potential drug target is at an early stage although there is an emerging understanding of a role in acute myeloid leukemia (AML). We report the optimization of fragment hit 5b to 13-d as a biased, potent inhibitor of the BRD of the BRPFs with excellent selectivity over nonclass IV BRD proteins. Evaluation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
49
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 39 publications
(49 citation statements)
references
References 44 publications
(81 reference statements)
0
49
0
Order By: Relevance
“…Interestingly, a newly described quinoline-2-one inhibitor targeting mainly BRPF1 and BRPF2 BDs also shows low micromolar activity in leukemia cell lines. 48 …”
Section: Results and Discussionmentioning
confidence: 99%
“…Interestingly, a newly described quinoline-2-one inhibitor targeting mainly BRPF1 and BRPF2 BDs also shows low micromolar activity in leukemia cell lines. 48 …”
Section: Results and Discussionmentioning
confidence: 99%
“…Such as et provedt oh ave higher shape diversity than that of other commercially available fragment libraries, as shown by the PMI plot (Figure 8), because the 52 NP-like fragments (black diamonds) significantly shifted towardsthe sphere corner. The biological relevance of this set of fragments was preliminarily demonstrated, thankst oahigh-throughput X-ray crystallographya ssay against three epigenetic targets, namely,t he ATAD2 [49] and BRD1 [50] bromodomains, and the histone demethylase JMJD2D. [51] Twoh its were found to interactw ith the JMJD2D protein, both of which targeted ap eripheral binding site, not previously detected in similar experiments,w hich could open up aw ay to new allosteric modulation of this histone demethylase enzyme.…”
Section: Assessing Structural Diversity Through Pca Plotsmentioning
confidence: 71%
“…Here, the objective was to perform a preliminary assessment of biological relevance rather than to provide specific starting points for discovery. High expression levels of ATAD2 and JMJD2 family members correlate with poor outcomes in several cancers, whilst BRD1 is a member of the BRPF family of scaffolding proteins whose role in acute myeloid leukemia is now emerging . The two bromodomains are contrasting targets: ATAD2 has a shallow N ‐acetyl lysine binding site and has been suggested to have particularly low druggability…”
Section: Resultsmentioning
confidence: 99%